Imagine your child scratching herself so unstoppably through the night that she wakes with blood-stained sheets. Nothing soothes her. You haven’t slept through the night in years. At school, unable to focus, she takes off her shoes and socks to scratch her feet on the carpet. The itch is inescapable. She has a life-threatening liver disease, and it’s getting worse.
Now imagine that you work for a company with a chance to help this child and her family.
This is Albireo. We are relentlessly focused on liver disease with the belief that bile acid modulation offers an innovative way to treat numerous rare and more common diseases affecting people worldwide. We are building a collaborative, committed, employee-friendly company, as we work to make this vision a reality.
Albireo is a public clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat rare childhood liver disease and other liver or gastrointestinal diseases and disorders. Albireo has deep expertise in bile acid biology and a clinical pipeline of three mid to late-stage product candidates designed to act locally to restore normal bile acid levels and treat diseases associated with irregularities in bile acid biology.
Albireo’s lead program is developing a therapy to treat patients with Progressive Familial Intrahepatic Cholestasis (PFIC). The Company initiated its global phase 3 study of A4250 in patients with PFIC in 2018 and expects topline results in mid-2020, with a projected potential first regulatory approval and launch in 2021.
Albireo was spun out from AstraZeneca in 2008 and is led by Ron Cooper, Albireo’s first President & CEO. Ron Cooper is a global P&L leader who joined Albireo after a distinguished career at Bristol Myers Squibb, including serving as BMS’s President of Europe, where he was responsible for 30 countries and sales exceeding $4.5B.
Albireo is located in Boston, Massachusetts (Financial District), and its key operating subsidiary, Albireo AB, is located in Gothenburg, Sweden.
Job Title: Medical Science Liaison/Senior Medical Science Liaison
Reports To: VP and Head of Global Medical Affairs
The Medical Science Liaison is a field-based scientific and clinical expert who strategically supports Albireo’s medical and scientific objectives. The MSL is responsible for identifying, developing and managing peer-to-peer relationships with a variety of healthcare professionals including pediatric hepatologists, gastroenterologists and surgeons.
He/she will be accountable to engage in high quality communications regarding the science and clinical applications of portfolio to variety of external stakeholders, as well as obtain important insights about current practice, treatment landscapes, and emerging clinical and scientific data. In addition, the MSL is expected to build strong cross-functional relationships, as well as provide meaningful subject-matter experts, to other colleagues at Albireo, in a fully compliant manner.
Key Duties and Responsibilities:
Partnership & Commitment
We believe that people and relationships ultimately determine success. We are committed to achieving excellence in everything we do. We strive to identify, attract and develop the best talent for our business, focusing on execution and teamwork.
Enjoyment & Creativity
We encourage individual creativity but believe that team effort produces the best results. We promote opportunities to contribute, providing a positive environment of curiosity and development. In the rapidly changing world of drug development, we work to anticipate changes and develop innovative approaches to meeting our goals.
Mutual Trust & Respect
We value diversity and strive to provide an inviting and inclusive environment. We seek to inspire trust and respect by taking responsibility for our actions, maintaining high ethical standards and encouraging collaboration and honest and straightforward communication.
Equal Opportunity Employer
All applicants should be legally entitled to work for any employer in the U.S.
Note to employment agencies: Please do not forward any agency resumes.